Ron Bentsur - 22 Jun 2022 Form 4 Insider Report for Nuvectis Pharma, Inc. (NVCT)

Signature
/s/ Ron Bentsur
Issuer symbol
NVCT
Transactions as of
22 Jun 2022
Net transactions value
+$8,462
Form type
4
Filing time
27 Jun 2022, 08:31:52 UTC
Previous filing
31 May 2022
Next filing
30 Jun 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVCT Common Stock Purchase $1,310 +100 +0% $13.10 2,963,714 22 Jun 2022 Direct F1
transaction NVCT Common Stock Purchase $2,280 +200 +0.01% $11.40 2,963,914 23 Jun 2022 Direct F1
transaction NVCT Common Stock Purchase $4,872 +400 +0.01% $12.18 2,964,314 24 Jun 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 96,759 shares of restricted stock and 120,000 restricted stock units.
F2 Reflects the weighted average purchase price. The range of prices for the shares purchased was $12.01 to $12.34. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price.